Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 - Diagnosis, Therapeutic Targets, and Molecular Mechanisms (Hardcover)


Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume Two: Diagnosis, Therapeutic Targets and Molecular Mechanisms for Hepatocellular Carcinoma Progression provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. The volume discusses topics such as computational approaches for identification of biomarkers, enzymes and pathways of HCC, circulating and epigenetic biomarkers, drug resistance, metabolic pathways, and small molecule-target therapies. In addition, it discusses immunotherapies, immune check point inhibitors and nanotechnology-based therapies. This book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.

R3,450

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles34500
Mobicred@R323pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days



Product Description

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume Two: Diagnosis, Therapeutic Targets and Molecular Mechanisms for Hepatocellular Carcinoma Progression provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. The volume discusses topics such as computational approaches for identification of biomarkers, enzymes and pathways of HCC, circulating and epigenetic biomarkers, drug resistance, metabolic pathways, and small molecule-target therapies. In addition, it discusses immunotherapies, immune check point inhibitors and nanotechnology-based therapies. This book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Academic Press Inc

Country of origin

United Kingdom

Release date

April 2022

Availability

Expected to ship within 12 - 17 working days

First published

2022

Editors

,

Dimensions

235 x 191mm (L x W)

Format

Hardcover

Pages

398

ISBN-13

978-0-323-98807-0

Barcode

9780323988070

Categories

LSN

0-323-98807-5



Trending On Loot